The typical case for the fund is to invest in rounds with 7 participants. Despite the Hestia Investments, startups are often financed by National Institutes of Health. The meaningful sponsors for the fund in investment in the same round are Novartis, MINTS, InvestMichigan. In the next rounds fund is usually obtained by Invest Michigan, InFocus Capital Partners, Capital Community Angel Investors.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Pharmaceutical, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight ONL Therapeutics.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The important activity for fund was in 2017. The fund is constantly included in less than 2 deals per year.
Besides them, we counted 2 critical employees of this fund in our database.
Related Funds
| Fund Name | Location |
| Clearstream | Luxembourg, Luxembourg |
| Fashion For Good | Amsterdam, Noord-Holland, The Netherlands |
| LSP Health Economics Fund | - |
| Office of the Chief Scientist of Israel - OCS | Israel, Tel Aviv, Tel Aviv |
| Portview Communications Partners | Armonk, New York, United States |
| Studio Management | California, San Francisco, United States |
| T-Mobile | Bellevue, United States, Washington |
| The Draper Richards Kaplan Foundation | California, Menlo Park, United States |
| Vertex Ventures Southeast Asia & India | Central Region, Singapore, Singapore |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Aikon | $10M | 29 Sep 2022 | San Francisco, California, United States | ||
Tvasta | $390K | 21 Oct 2021 | Bengaluru, Karnataka, India | ||
ONL Therapeutics | $4M | 17 May 2017 | Ann Arbor, Michigan, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Aikon | $10M | 29 Sep 2022 | San Francisco, California, United States | ||
Tvasta | $390K | 21 Oct 2021 | Bengaluru, Karnataka, India | ||
ONL Therapeutics | $4M | 17 May 2017 | Ann Arbor, Michigan, United States |
